Study calls out the genes that make cancer cells so hard to kill

Researchers from the University of Toronto published a new map of cancer cells' genetic defenses against treatment.

DNA strand and cancer cell 3D rendering
Credit: CI Photos/Shutterstock
  • Developing immunotherapies for cancers is made more difficult by how different tumors are from each other.
  • Some cancers are actually made worse by immunotherapy.
  • A piece falls into place on the complicated puzzle of genetic interactions of cancer cells.

    • There's a great diversity among cancer cells, though many of them share one unfortunate trait: They're often quite adept at resisting the body's immune system. The immune system's T killer cells can theoretically take out cancer cells, and immunotherapies enhance existing T cells' potency. Still, cancer cells are often impervious to them, can mutate to evade them, and worst of all, can acquire "cancer resistance mutations" that cause the disease to worsen in response to T cells. This is especially true of the cells in solid tumors.

      A study from researchers at University of Toronto catalogs the genes in cancer tumors that allow the disease to so effectively resist immunotherapy. Its authors hope that their findings will eventually lead to the development of more successful cancer treatments.

      The study is published in the journal Nature.

      A moving target

      IV drip

      Credit: Marcelo Leal/Unsplash

      Speaking to U of T News, lead author of the study molecular geneticist Jason Moffat of the university's Donnelly Centre for Cellular and Biomolecular Research says, "Over the last decade, different forms of immunotherapy have emerged as really potent cancer treatments, but the reality is that they only generate durable responses in a fraction of patients and not for all tumor types."

      There can be a significant degree of heterogeneity between cancer cells from human to human, and even within the same person, making the development of therapies maddeningly difficult. Attempting to address potential cancer-cell vulnerabilities across these variations is a life-or-death game of whack-a-mole.

      "It's an ongoing battle between the immune system and cancer, where the immune system is trying to find and kill the cancer whereas the cancer's job is to evade that killing," says Moffat.

      Mapping the mechanisms

      Illustration: genes (red, green, and blue spots within the nuclei of HeLa cells) artificially superimposed on images of multi-well plates.

      Credit: National Cancer Institute/Unsplash

      Moffat and his colleagues decided to investigate and identify genes within cancer cells that help them defeat treatment. Co-lead author Keith Lawson of Moffat's lab explains that "it's important to not just find genes that can regulate immune evasion in one model of cancer, but what you really want are to find those genes that you can manipulate in cancer cells across many models because those are going to make the best therapeutic targets."

      To accomplish this, the researchers, working with scientists at Agios Pharmaceuticals in Cambridge, Massachusetts, first exposed cells from breast, colon, kidney and skin cancer tumors to T cells in lab dishes. This established a baseline of their responses to treatment. Next, using CRISPR, the scientists went through the cells, exhaustively turning off one gene at a time to determine its role in immunotherapy resistance by comparing the cells' response to the T cells compared to their original baseline response.

      The team identified 182 "core cancer intrinsic immune evasion genes" that affected the cells' response to T cells. The fact that some of the identified genes were already known to be involved in resistance provided the researchers with some confidence that they were on the right track.

      Still, many of the genes they ID'ed had not been previously implicated. "That was really exciting to see because it means that our dataset was very rich in new biological information," says Lawson.

      It's complicated

      Unfortunately, Moffat's research also makes clear that defeating cancer-cell resistance is not as simple as removing certain genes. It's true that when the team switched off some of the genes they'd identified, the cancer cells became more vulnerable to T cells, but on the other hand, removal of some other genes made the cancer cells more resistant.

      There also appear to be relationships between multiple genes that complicate matters.

      The team explored the manipulation of the genes that allow cancer cells to engage in autophagy, the process by which cells clear out no-longer useful materials to facilitate speedy recovery from damage. Surprisingly, when the researchers deleted certain genes responsible for cancer cells' autophagy, they found the cells' resistance to T cells increased. Apparently, removing one autophagy gene strengthened another mutated autophagy gene.

      "We found this complete inversion of gene dependency," said Moffat. "We did not anticipate this at all. What it shows us is that genetic context — what mutations are present — very much dictates whether the introduction of the second mutation will cause no effect, resistance or sensitivity to therapy."

      There remains a long road ahead when it comes to unraveling cancer cells' resistance to immunotherapy. However, this new study presents a new map that can help scientists navigate what comes next.

      Iron Age discoveries uncovered outside London, including a ‘murder’ victim

      A man's skeleton, found facedown with his hands bound, was unearthed near an ancient ceremonial circle during a high speed rail excavation project.

      Photo Credit: HS2
      Culture & Religion
      • A skeleton representing a man who was tossed face down into a ditch nearly 2,500 years ago with his hands bound in front of his hips was dug up during an excavation outside of London.
      • The discovery was made during a high speed rail project that has been a bonanza for archaeology, as the area is home to more than 60 ancient sites along the planned route.
      • An ornate grave of a high status individual from the Roman period and an ancient ceremonial circle were also discovered during the excavations.
      Keep reading Show less

      Are lab–grown embryos and human hybrids ethical?

      This spring, a U.S. and Chinese team announced that it had successfully grown, for the first time, embryos that included both human and monkey cells.

      Getty Images
      Surprising Science
      In Aldous Huxley's 1932 novel “Brave New World," people aren't born from a mother's womb. Instead, embryos are grown in artificial wombs until they are brought into the world, a process called ectogenesis.
      Keep reading Show less

      A big lesson from the ‘Oumuamua alienware controversy

      Scientists should be cautious when expressing an opinion based on little more than speculation.

      Artist's impression of ʻOumuamua

      Credit: European Southern Observatory/M. Kornmesser
      • In October 2017, a strange celestial object was detected, soon to be declared our first recognized interstellar visitor.
      • The press exploded when a leading Harvard astronomer suggested the object to have been engineered by an alien civilization.
      • This is an extraordinary conclusion that was based on a faulty line of scientific reasoning. Ruling out competing hypotheses doesn't make your hypothesis right.
      Keep reading Show less
      Surprising Science

      Asteroid impact: NASA simulation shows we are sitting ducks

      Even with six months' notice, we can't stop an incoming asteroid.